These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36339467)

  • 21. Incidence and predictors of silent cerebral thromboembolic lesions after catheter ablation for atrial fibrillation in patients treated with direct oral anticoagulants.
    Doi A; Takagi M; Kakihara J; Hayashi Y; Tatsumi H; Fujimoto K; Sugioka K; Yoshiyama M
    Heart Vessels; 2017 Oct; 32(10):1227-1235. PubMed ID: 28466408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimally Interrupted Non-Vitamin K Antagonist Oral Anticoagulants vs. Bridging Therapy and Uninterrupted Vitamin K Antagonists During Atrial Fibrillation Ablation: A Retrospective Single-Center Study.
    Tang L; Liu H; Deng H; Zhan X; Fang X; Liao H; Liu Y; Fu L; Fu Z; Liu H; Wu S; Xue Y
    Front Med (Lausanne); 2020; 7():197. PubMed ID: 32582721
    [No Abstract]   [Full Text] [Related]  

  • 23. Safety of Catheter Ablation of Atrial Fibrillation Under Uninterrupted Rivaroxaban Use.
    Silva MA; Futuro GMC; Merçon ES; Vasconcelos D; Agrizzi RS; Elias Neto J; Kuniyoshi R
    Arq Bras Cardiol; 2020 Mar; 114(3):435-442. PubMed ID: 32049156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
    Rillig A; Lin T; Plesman J; Heeger CH; Lemes C; Metzner A; Mathew S; Wissner E; Wohlmuth P; Ouyang F; Kuck KH; Tilz RR
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):147-53. PubMed ID: 26464027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apixaban, rivaroxaban, and dabigatran use in patients undergoing catheter ablation for atrial fibrillation using the second-generation cryoballoon.
    Tscholl V; Lsharaf AK; Lin T; Bellmann B; Nagel P; Lenz K; Landmesser U; Roser M; Rillig A
    Clin Cardiol; 2017 Nov; 40(11):1095-1099. PubMed ID: 28846806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated Clotting Time Monitoring during Atrial Fibrillation Catheter Ablation: Does the Anticoagulant Matter?
    Martin AC; Kyheng M; Foissaud V; Duhamel A; Marijon E; Susen S; Godier A
    J Clin Med; 2020 Jan; 9(2):. PubMed ID: 32012701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated clotting time on the day of atrial fibrillation ablation for minimally interrupted and uninterrupted direct oral anticoagulation therapy: Sequential changes, differences among direct oral anticoagulants, and ablation safety outcomes.
    Yamaji H; Murakami T; Hina K; Higashiya S; Kawamura H; Murakami M; Kamikawa S; Hirohata S; Kusachi S
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2823-2833. PubMed ID: 31701593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin.
    Konduru SV; Cheema AA; Jones P; Li Y; Ramza B; Wimmer AP
    J Interv Card Electrophysiol; 2012 Dec; 35(3):277-84; discussion 284. PubMed ID: 23015216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose dabigatran versus uninterrupted acenocoumarol for peri-procedural anticoagulation in atrial fibrillation catheter ablation.
    Efremidis M; Vlachos K; Letsas KP; Giannopoulos G; Lioni L; Georgopoulos S; Vadiaka M; Deftereos S; Sideris A
    J Electrocardiol; 2015; 48(5):840-4. PubMed ID: 26152604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel protocol for initial heparin administration during catheter ablation for atrial fibrillation in patients taking direct oral anticoagulants.
    Kishima H; Mine T; Fukuhara E; Ashida K; Ishihara M; Masuyama T
    Heart Vessels; 2019 May; 34(5):832-841. PubMed ID: 30390125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
    Kaiser DW; Streur MM; Nagarakanti R; Whalen SP; Ellis CR
    J Interv Card Electrophysiol; 2013 Sep; 37(3):241-7. PubMed ID: 23625091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation.
    Aoyama D; Miyazaki S; Hasegawa K; Kaseno K; Ishikawa E; Mukai M; Miyahara K; Aiki T; Matsui A; Yamaguchi J; Shiomi Y; Tama N; Ikeda H; Fukuoka Y; Morishita T; Ishida K; Uzui H; Tada H
    Int Heart J; 2019 Nov; 60(6):1315-1320. PubMed ID: 31735780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catheter ablation of left atrial arrhythmias on uninterrupted oral anticoagulation with vitamin K antagonists: What is the relationship between international normalized ratio, activated clotting time, and procedure-related complications?
    Kottmaier M; Bourier F; Semmler V; Telishevska M; Koch-Büttner K; Lennerz C; Lengauer S; Kornmayer M; Rousseva E; Brooks S; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I; Reents T
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1415-1422. PubMed ID: 28800176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH; Camm J; Cappato R; Diener HC; Heidbuchel H; Lanz HJ; Mont L; Morillo CA; Smolnik R; Yin OQP; Kautzner J
    Clin Cardiol; 2018 Apr; 41(4):440-449. PubMed ID: 29663464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
    Calkins H; Willems S; Gerstenfeld EP; Verma A; Schilling R; Hohnloser SH; Okumura K; Serota H; Nordaby M; Guiver K; Biss B; Brouwer MA; Grimaldi M;
    N Engl J Med; 2017 Apr; 376(17):1627-1636. PubMed ID: 28317415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillation.
    Sairaku A; Yoshida Y; Ando M; Hirayama H; Nakano Y; Kihara Y
    Clin Drug Investig; 2013 Nov; 33(11):847-53. PubMed ID: 24081373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of Rivaroxaban anticoagulant therapy in the treatment of atrial fibrillation cryoablation].
    Di CY; Wan Z; Lin WH
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(33):2591-2594. PubMed ID: 28881533
    [No Abstract]   [Full Text] [Related]  

  • 38. Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
    Maddox W; Kay GN; Yamada T; Osorio J; Doppalapudi H; Plumb VJ; Gunter A; McElderry HT
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):861-5. PubMed ID: 23577951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J-CARAF)-A report on periprocedural oral anticoagulants.
    Murakawa Y; Nogami A; Shoda M; Inoue K; Naito S; Kumagai K; Miyauchi Y; Yamane T; Morita N; Mitamura H; Okumura K;
    J Arrhythm; 2015 Feb; 31(1):29-32. PubMed ID: 26336520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation.
    Providência R; Marijon E; Albenque JP; Combes S; Combes N; Jourda F; Hireche H; Morais J; Boveda S
    Europace; 2014 Aug; 16(8):1137-44. PubMed ID: 24550347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.